Advertisement

Laboratory Diagnosis of HBV

  • Şükran Köse
  • Tuba Dal
Chapter

Abstract

Hepatitis B virus (HBV) is an enveloped virus with a genome composed by partially double-stranded DNA. The diagnosis of HBV infection is generally based on serological and molecular assays. Enzyme immunoassays are the most important serological assays identifying virus-encoded antigens and their corresponding antibodies. The molecular tests focus on the detection of quantitative viral load, drug resistance mutations, genotyping, and core promotion/precore mutation assays. The fully automated real-time polymerase chain reaction (PCR) methods are considered as standard methods to detect and quantify HBV DNA because of their high capacity to detect a wide dynamic range of viral load and due to lack of carry-over contamination. Biosensors and biochips seem to be useful technologies for serological diagnosis of HBV. Ultra-deep sequencing technologies will be useful for the analysis of HBV mutants in order to study the dynamics of viral variants.

Keywords

Hepatitis B virus Enzyme immunoassays Real-time PCR Sequencing 

References

  1. 1.
    Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni L de P. Update on hepatitis B and C virus diagnosis. World J Virol. 2015;4(4):323–42.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141–50.CrossRefPubMedGoogle Scholar
  3. 3.
    World Health Organization. Hepatitis B, fact sheet No. 204. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed May 2005.
  4. 4.
    Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Chiba J, Ohba H, Matsuura Y, Watanabe Y, Katayama T, Kikuchi S, Saito I, Miyamura T. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci U S A. 1991;88:4641–5.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Liu Y-P, Yao C-Y. Rapid and quantitative detection of hepatitis B virus. World J Gastroenterol. 2015;21(42):11954–63.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dény P, Zoulim F. Hepatitis B virus: from diagnosis to treatment. Pathol Biol (Paris). 2010;58:245–53.CrossRefGoogle Scholar
  8. 8.
    Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, Wong GL, Sung JJ. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol. 2007;5(12):1462–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Kao J-H. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol. 2008;2(4):553–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Chudy M, Scheiblauer H, Hanschmann KM, Kress J, Nick S, Wend U, Schüttler C, Nübling CM, Gerlich WH. Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel. J Clin Virol. 2013;58:47–53.CrossRefPubMedGoogle Scholar
  11. 11.
    Mühlbacher A, Weber B, Bürgisser P, Eiras A, Cabrera J, Louisirirotchanakul S, et al. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol. 2008;197:55–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Chen E-Q, Feng S, Wang M-L, Liang L-B, Zhou L-Y, et al. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B. Sci Rep. 2017;7:173.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010;98:403–14.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ghosh M, Nandi S, Dutta S, Saha MK. Detection of hepatitis B virus infection: a systematic review. World J Hepatol. 2015;7(23):2482–91.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Khuroo MS, Khuroo NS, Khuroo MS. Accuracy of rapid point-of-care diagnostic tests for hepatitis B surface antigen-a systematic review and meta-analysis. J Clin Exp Hepatol. 2014;4:226–40.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Njai HF, Shimakawa Y, Sanneh B, Ferguson L, Ndow G, Mendy M, Sow A, et al. Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. J Clin Microbiol. 2015;53(4):1156–63.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz. 2006;101:149–55.CrossRefPubMedGoogle Scholar
  18. 18.
    Forbi JC, Obagu JO, Gyar SD, Pam CR, Pennap GR, Agwale SM. Application of dried blood spot in the sero-diagnosis of hepatitis B infection (HBV) in an HBV hyper-endemic nation. Ann Afr Med. 2010;9:44–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee CE, Sri Ponnampalavanar S, Syed Omar SF, Mahadeva S, Ong LY, Kamarulzaman A. Evaluation of the dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab, HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital. Ann Acad Med Singap. 2011;40:448–53.PubMedGoogle Scholar
  20. 20.
    Villar LM, de Oliveira JC, Cruz HM, Yoshida CF, Lampe E, Lewis-Ximenez LL. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers. J Med Virol. 2011;83:1522–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Uliana CV, Riccardi CS, Yamanaka H. Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis. World J Gastroenterol. 2014;20:15476–91.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Yao CY, Fu WL. Biosensors for hepatitis B virus detection. World J Gastroenterol. 2014;20:12485–92.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Wang X, Li Y, Wang H, Fu Q, Peng J, Wang Y, Du J, Zhou Y, Zhan L. Gold nanorod-based localized surface plasmon resonance biosensor for sensitive detection of hepatitis B virus in buffer, blood serum and plasma. Biosens Bioelectron. 2010;26:404–10.CrossRefPubMedGoogle Scholar
  24. 24.
    Fakruddin M, Mannan KS, Chowdhury A, Mazumdar RM, Hossain MN, Islam S, Chowdhury MA. Nucleic acid amplification: alternative methods of polymerase chain reaction. J Pharm Bioallied Sci. 2013;5:245–52.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol. 1999;37:2899–903.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Baylis SA, Heath AB, Chudy M, Pisani G, Klotz A, Kerby S, Gerlich W. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays. Vox Sang. 2008;94:358–62.CrossRefPubMedGoogle Scholar
  27. 27.
    Sanders R, Huggett JF, Bushell CA, Cowen S, Scott DJ, Foy CA. Evaluation of digital PCR for absolute DNA quantification. Anal Chem. 2011;83:6474–84.CrossRefPubMedGoogle Scholar
  28. 28.
    Huang JT, Liu YJ, Wang J, Xu ZG, Yang Y, Shen F, Liu XH, Zhou X, Liu SM. Next generation digital PCR measurement of hepatitis B virus copy number in formalin-fixed paraffin-embedded hepatocellular carcinoma tissue. Clin Chem. 2015;61:290–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Landegren U, Kaiser R, Sanders J, Hood L. A ligase-mediated gene detection technique. Science. 1988;241:1077–80.CrossRefPubMedGoogle Scholar
  30. 30.
    Lisby G. Application of nucleic acid amplification in clinical microbiology. Mol Biotechnol. 1999;12:75–99.CrossRefPubMedGoogle Scholar
  31. 31.
    Abravaya K, Carrino JJ, Muldoon S, Lee HH. Detection of point mutations with a modified ligase chain reaction (Gap-LCR). Nucleic Acids Res. 1995;23:675–82.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Minamitani S, Nishiguchi S, Kuroki T, Otani S, Monna T. Detection by ligase chain reaction of precore mutant of hepatitis B virus. Hepatology. 1997;25:216–22.CrossRefPubMedGoogle Scholar
  33. 33.
    Trippler M, Hampl H, Goergen B, Spies U, Knolle P, Grimm B, Meyer zum Büschenfelde KH, Gerken G. Ligase chain reaction (LCR) assay for semi-quantitative detection of HBV DNA in mononuclear leukocytes of patients with chronic hepatitis B. J Viral Hepat. 1996;3:267–72.CrossRefPubMedGoogle Scholar
  34. 34.
    Datta S, Chatterjee S, Veer V. Recent advances in molecular diagnostics of hepatitis B virus. World J Gastroenterol. 2014;20(40):14615–25.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Nagamine K, Hase T, Notomi T. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes. 2002;16:223–9.CrossRefGoogle Scholar
  36. 36.
    Parida M, Sannarangaiah S, Dash PK, Rao PV, Morita K. Loop mediated isothermal amplification (LAMP): a new generation of innovative gene amplification technique; perspectives in clinical diagnosis of infectious diseases. Rev Med Virol. 2008;18:407–21.CrossRefPubMedGoogle Scholar
  37. 37.
    Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip. 2012;12:2469–86.CrossRefPubMedGoogle Scholar
  38. 38.
    Cai T, Lou G, Yang J, Xu D, Meng Z. Development and evaluation of real-time loop-mediated isothermal amplification for hepatitis B virus DNA quantification: a new tool for HBV management. J Clin Virol. 2008;41:270–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Compton J. Nucleic acid sequence-based amplification. Nature. 1991;350:91–2.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Deiman B, Jay C, Zintilini C, Vermeer S, van Strijp D, Venema F, van de Wiel P. Efficient amplification with NASBA of hepatitis B virus, herpes simplex virus and methicillin resistant Staphylococcus aureus DNA. J Virol Methods. 2008;151:283–93.CrossRefPubMedGoogle Scholar
  41. 41.
    Yates S, Penning M, Goudsmit J, Frantzen I, van de Weijer B, van Strijp D, van Gemen B. Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection. J Clin Microbiol. 2001;39:3656–65.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Gulliksen A, Solli L, Karlsen F, Fire A, Xu SQ. Rolling replication of short DNA circles. Proc Natl Acad Sci U S A. 1995;92:4641–5.CrossRefGoogle Scholar
  43. 43.
    Margeridon S, Carrouée-Durantel S, Chemin I, Barraud L, Zoulim F, Trépo C, Kay A. Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother. 2008;52:3068–73.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Martel N, Gomes SA, Chemin I, Trépo C, Kay A. Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA). J Virol Methods. 2013;193:653–9.CrossRefPubMedGoogle Scholar
  45. 45.
    Kamisango K, Kamogawa C, Sumi M, Goto S, Hirao A, Gonzales F, Yasuda K, Iino S. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol. 1999;37:310–4.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Newman JD, Tigwell LJ, Turner APF, Warner PJ. Biosensors A clearer view. In: Proceedings of the 8th world congress on biosensors; 2004; May 24–26. Granada: Cranfield University Publication; 2004. p. 17–20.Google Scholar
  47. 47.
    Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437:376–80.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis. 2009;199:1275–85.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Şükran Köse
    • 1
  • Tuba Dal
    • 2
  1. 1.Department of Infectious Diseases and Clinical MicrobiologyUniversity of Health Science, Tepecik Training and Research HospitalİzmirTurkey
  2. 2.Department of Medical MicrobiologyAnkara Yildirim Beyazıt University Medical FacultyAnkaraTurkey

Personalised recommendations